Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma.

Mohammed H Ahmed,Isaias Hernández-Verdin,Franck Bielle,Maïté Verreault,Julie Lerond,Agusti Alentorn,Marc Sanson,Ahmed Idbaih

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques（2023）

引用 2|浏览13

暂无评分

摘要

CD86 could be used as a potential biomarker for the prognosis of GBM patients treated with immunotherapy; however, additional studies are needed to validate these findings.

查看译文

关键词

Glioblastoma,Immune checkpoint proteins,Microenvironment,Prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要